Measuring Preferences for Cost-Utility Analysis

neonatal screening: cost-utility analysis for galactosemia

background: galactosemia is a congenital metabolic disorder that can damage the health of a newborn. screening is an important step to prevent and treat this condition. due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool should be applied. the aim of this study was to analyze the cost-utility of neonatal screening progr...

Utility Estimation of Health Status of Cancer Patients by Mapping for Cost-Utility Analysis

Background: It is important to obtain accurate information about the preferences of people for measuring quality-adjusted life years (QALYs), because it is necessary for cost-utility analysis. In this regard, mapping is a method to access this information. Therefore, the purpose of this study was to map Functional Assessment of Cancer Therapy – General (FACT-G) onto Short Form Six Dimension (SF...

A cost–utility analysis

Neurology S. Claiborne Johnston, Daryl R. Gress and James G. Kahn Which unruptured cerebral aneurysms should be treated?: A cost–utility analysis This information is current as of January 25, 2006 http://www.neurology.org/cgi/content/full/52/9/1806 located on the World Wide Web at: The online version of this article, along with updated information and services, is Print ISSN: 0028-3878. Online ...

Neonatal Screening: Cost-utility Analysis for Galactosemia

BACKGROUND Galactosemia is a congenital metabolic disorder that can damage the health of a newborn. Screening is an important step to prevent and treat this condition. Due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool should be applied. The aim of this study was to analyze the cost-utility of neonatal screening progra...

Decision Modeling for Cost-Utility Analysis.